This week's largest increase in margin financing balance: KEBODA margin financing balance: 449 million yuan, balance increase: 161.46%; ZHENDE MEDICAL margin financing balance: 544 million yuan, balance increase: 124.55%

ZHENDE MEDICAL rose 6.90% today, with one institutional special seat net selling 102 million yuan

ZHENDE MEDICAL rose 6.90% today, with a transaction amount of 1.109 billion yuan and a turnover rate of 11.48%. According to the after-hours dragon and tiger list data, the Shanghai Stock Connect special seat bought 52.3103 million yuan and sold 54.9025 million yuan, with 1 institutional special seat net selling 102 million yuan

Sun Jimu signed the share transfer agreement 5% stake in Zhende Medical Co., Ltd. from Zhejiang Zhende Holding Co., Ltd. for approximately CNY 360 million.

Sun Jimu has signed a share transfer agreement to acquire a 5% stake in Zhende Medical Co., Ltd. from Zhejiang Zhende Holding Co., Ltd. for approximately CNY 360 million. The transaction, finalized on September 10, 2025, involves a cash payment of CNY 356.25 million for 13.3 million shares. Following the transfer, Zhejiang Zhende Holding Co., Ltd. and its affiliates will hold a combined 54.20% stake in the company, while Sun Jimu will hold 5.00%.

ZHENDE MEDICAL's controlling shareholder and concerted parties plan to transfer 5% of the company's shares through an agreement

ZHENDE MEDICAL's controlling shareholder Zhejiang ZHENDE and its wholly-owned subsidiary Xuchang Garden intend to transfer 5% of the company's shares, totaling 13.3226 million shares, at a transfer price of 26.74 yuan per share, with a total price of 356 million yuan. After the transfer, the shareholding ratio of the controlling shareholder and its concerted parties will decrease to 54.20%. The transferee Sun Jimu has committed not to reduce the acquired shares within 12 months

Global Undiscovered Gems Featuring Shanghai Yaohua Pilkington Glass Group And Two Promising Small Caps

The article discusses the resilience of smaller-cap stocks amid fluctuating global markets, highlighting Shanghai Yaohua Pilkington Glass Group and Zhende Medical as promising investments. Shanghai Yaohua has shown impressive earnings growth of 282.5% and improved debt management, while Zhende Medical reported a 188% earnings increase despite a slight dip in net income. Both companies are positioned for stability and growth, with strong fundamentals and strategic initiatives enhancing their market presence. The article emphasizes the importance of identifying undiscovered gems in the current economic landscape.